Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Research and Markets
DUBLIN, Apr. 29, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/557vt9/life_sciences_bpo) has announced the addition of the "Life Sciences BPO Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering.
The life sciences BPO market comprises services offered by Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs) to the biotech pharmaceutical companies. A rise in demand for low-cost drugs, patent expirations and uncertain economic conditions have compelled the pharmaceutical players to take support of various outsourcing services. This support has facilitated pharma players to streamline their value chain and focus more on its core strategies. Pharmaceutical companies are now forming long term partnership with the CROs and CMOs to share the costs involved in drug discovery to post marketing approvals. Moreover, they are also leveraging CROs and CMOs expertise such as use of novel technologies, trained staff and previous experiences for effective outcomes.
The research report on life sciences BPO provides detailed analysis of the global market and helps in understanding the driving forces responsible for the growth of this market. The report discusses the market of life sciences BPO on the basis of different CRO and CMO services. The CRO services comprises clinical data management, monitoring, medical writing, regulatory services, pharmacovigilance, bio-statistics, drug discovery and pre-clinical tests. The CMO services include API manufacturing, Finished Dosage Formulation development and manufacturing and Packaging.
The global life sciences BPO market has been segmented based on all the above-mentioned parameters and market size estimates and forecasts for the period of 2011 to 2019 have been provided for each of the segments, in terms of USD million, considering 2012 as the base year for calculations and 2011 representing as the historical year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has also been provided along with market size estimations.
The report exclusively studies the aforementioned segments with respect to geography. Under geographic section we have covered four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (ROW). Moreover, the European region has been further studied by various countries including U.K., Germany, France, Spain, Italy and Rest of Europe (ROE).
The report concludes with the competitive landscape and company profiles of major market players. These market players have been profiled on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Some of the major players profiled in this report includeCatalent Pharma Solutions, Inc., PRA International Inc., Covance Inc., Cognizant Technology Solutions, Quintiles Transnational Corporation, Parexel International Corporation, DSM, Charles River Laboratories, Piramal Healthcare and Boehringer Ingelheim GmbH.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Global Life Sciences BPO Market Dynamics
Chapter 4 Global Life Sciences BPO Market, by Segments
Chapter 5 Global Life Sciences BPO Market, by Geography
Chapter 6 Global Life Sciences BPO Market Share Analysis
Chapter 7 Recommendations
Chapter 8 Company Profiles
Chapter 9 List of the Companies
For more information visit http://www.researchandmarkets.com/research/557vt9/life_sciences_bpo
Media Contact: Laura Wood, +353-1-481-1716, email@example.com
©2012 PR Newswire. All Rights Reserved.